Medical News

RSS

BioRadar develops TransFMDV for Foot and Mouth Disease

BioRadar UK Ltd. predicted one year ago the current severe Foot and Mouth Disease (FMD) outbreaks after recording an increase of the Replikin Count (ref. 1) of the FMD Virus (FMDV) to its highest level in 52 years. Based on these findings, a new synthetic Replikins Trans-Strain FMD Vaccine, called TransFMDV(TM), has been developed and is now available. The announcement was made at the recent Biorbis Conference on Vaccine Production and Manufacturing in Amsterdam, the Netherlands. The conference was attended by major pharmaceutical company executives to examine how vaccine production could be accelerated in view of the problem last year of responding "too little, too late" to the H1N1 influenza pandemic.

17 Jul 2010

InformedDNA named finalist for Best Practices in Health Care Consumer Empowerment and Protection Awards

Informed Medical Decisions, Inc. (InformedDNA) has been selected as one of 30 finalists for the Best Practices in Health Care Consumer Empowerment and Protection Awards. URAC, the nation's leading accreditation organization, will honor the finalists during their 11th Annual Quality Summit, October 5-7, 2010 in Chicago, IL.

17 Jul 2010

Roper's Senior Subordinated Convertible Notes due 2034 to accrue contingent interest

Roper Industries, Inc. announced today that its Senior Subordinated Convertible Notes due 2034 will accrue contingent interest for the period of July 16, 2010 to January 15, 2011 at an annual rate of 0.25% of the average market price of the Notes for the five trading days ended July 13, 2010.

17 Jul 2010

Proton therapy treatment for anal canal cancer performed for first time in US

The INTEGRIS Cancer Institute of Oklahoma and the ProCure Proton Therapy Center announce a breakthrough treatment approach for anal canal cancer. For the first time in the United States proton therapy is now being used to treat this type of cancer.

17 Jul 2010

Ingen files patent to produce new drug insulin thermos product

Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company has also filed a U.S patent and will begin the required manufacturing processes to produce the new drug insulin thermos product.

17 Jul 2010

NCOA adds ILS as partner to sponsor Private Label version of online screening service for senior benefits

The National Council on Aging (NCOA) today announced the addition of Independent Living Systems (ILS) as the newest partner to sponsor a Private Label version of BenefitsCheckUp, NCOA's online screening service for senior benefits. The Private Label version of BenefitsCheckUp will allow ILS to enhance the care management services the company currently provides to its clients, many of whom are frail and underprivileged individuals who require chronic care or other special needs.

17 Jul 2010

Christiana Care ranked among top 50 of America's best hospitals in 2 specialties

In its annual Best Hospitals edition, US News & World Report places Christiana Care among the top 50 listings in 2 specialties – Gastroenterology and Urology.

17 Jul 2010

Florida Institute of Technology assists licensing CDNI-Glu compound to UK company

As a national research university, Florida Institute of Technology not only involves its students in research, but also seeks to license and patent its many innovations. An example of recently licensed university technology is a chemical compound that facilitates the work of neuroscientists in the laboratory.Associate Professor Nasri Nesnas was familiar as a chemist with the chemical compound CDNI-Glu, a commonly used laboratory research tool. Most often, neuroscientists use it to study the brain's neural networks by improving the localization of synaptic stimulation

17 Jul 2010

IAS announces winners of four scientific awards to be presented at AIDS 2010

The International AIDS Society (IAS) announced today the ten winners of four prestigious scientific awards, to be presented at plenary sessions during the XVIII International AIDS Conference (AIDS 2010). Presented by the IAS and partners, these awards recognize scientists involved in innovative HIV and AIDS research throughout the world. "The quality of work represented by the 2010 awardees is remarkable," said IAS President Julio Montaner. "The IAS hopes to draw the world's attention to these individuals and to their significant scientific accomplishments, as well as to the continued need for innovation in all of the major areas of HIV and AIDS research, represented by the six conference programme tracks."

17 Jul 2010

Resveratrol concentration impacts cancer risk mitigation: Study

Agricultural Research Service (ARS) chemist Thomas Wang, who specializes in cancer prevention research, has reported evidence that for some dietary compounds, length of exposure over time may be key to whether or not ingestion leads to a beneficial, or detrimental, effect.Scientists do not know exactly why one person develops cancer and another does not. But they do know that certain nutrients might increase or decrease cancer risk. There are "layers" of factors involved in the development of cancer, and Wang is studying the layers involving peoples' diet complexity and gene expression.

17 Jul 2010

ICON opens purpose-built clinical pharmacology unit within CMFT campus

ICON plc,, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the official opening of a purpose-built clinical pharmacology unit within the Central Manchester University Hospitals Foundation Trust (CMFT) campus in Manchester, UK. Initial studies in the unit utilising translational medicine methodologies to expedite drug development projects began in June, and already 110 volunteers have participated in studies there.

17 Jul 2010

Pacific Shore releases clinical trial results for Burner Balm lip balm

Pacific Shore Holdings, Inc., today announced the release of the highly anticipated clinical trial results for Burner Balm lip balm. According to lead clinical investigator, Dr. David E. Toomey, who has orchestrated a multitude of clinical trials for some of the top pharmaceutical manufacturers in the United States, "Over a twelve week period, 120 study participants who were overweight participated in the study. The Burner Balm group lost an average of 7 to 9 pounds versus the placebo group who lost an average of 1.43 to 1.64 pounds in the 12 week period.

17 Jul 2010

HealthCare Appraisers opens new office in Wayne, Pennsylvania

HealthCare Appraisers, Inc. (HAI) announced today that the firm has opened a new office in the Philadelphia area. The new office, in Wayne, Pennsylvania, is part of HAI's continued office expansion to provide fair market value (FMV) analysis and valuation services to the healthcare and life sciences industries nationwide.

17 Jul 2010

Cage type affects laboratory mice brain

Researchers at the University of Colorado's Anschutz Medical Campus have found the brains of mice used in laboratories worldwide can be profoundly affected by the type of cage they are kept in, a breakthrough that may require scientists to reevaluate the way they conduct future experiments.

17 Jul 2010

Aetna awards $75,000 grant to support Judge Glenda Hatchett's ParentPowerNow! anti-obesity program

Aetna announced today it will support Judge Glenda Hatchett's ParentPowerNow! anti-obesity program. "Parent Power Now!" is an online community of people interested in working together and learning more about parenting. Aetna has awarded a $75,000 grant and will provide health content for the ParentPowerNow! website, guest speakers to address healthy living on Judge Hatchett's live website radio program, and support for health events scheduled around the country.

17 Jul 2010

Study examines HIV-positive patients' death risk at CD4 counts above 350

"Having HIV appears to be associated with a greater risk of death, even when the immune system is relatively robust and patients have not started treatment," according to a study published Friday in the Lancet, MedPage Today reports (Smith, 7/15).

17 Jul 2010

Gluten free diet reduces inflammation, improves digestion

In 2008, the Garmin-Transitions US Cycling Team experimented with a gluten free diet as a way to improve performance by reducing inflammation, which is important for weeks-long races. The experiment was a success.

17 Jul 2010

MJO Staffing, U.S. Colleges of Health & Human Services announce strategic business collaboration

MJO Staffing, Inc. and U.S. Colleges of Health & Human Services announced today the creation of a strategic alliance. This business collaboration is designed to expand the opportunities for both students and recent graduates with additional internship and externship programs while teaming up with MJO Staffing Inc. to expand their employee pool of qualified talent. MJO Staffing will track the professional progression of experience for graduates maximizing their placement opportunities into a rewarding career.

17 Jul 2010

Pain medication abuse soars

The Associated Press: "A new government study finds a 400 percent increase in the number of people admitted to treatment for abusing prescription pain medication. The increase in substance abuse among people ages 12 and older was recorded during the 10-year-period from 1998 to 2008. It spans every gender, race, ethnicity, education and employment level, and all regions of the country" (7/15).

17 Jul 2010

Apicore announces successful conclusion of Somerset API manufacturing plant's FDA inspection

Apicore LLC announced today that the U.S. Food and Drug Administration (FDA) completed an inspection of its API manufacturing plant in Somerset, New Jersey on July 13, 2010.

17 Jul 2010

Medical News

BioRadar develops TransFMDV for Foot and Mouth Disease

InformedDNA named finalist for Best Practices in Health Care Consumer Empowerment and Protection Awards

Roper's Senior Subordinated Convertible Notes due 2034 to accrue contingent interest

Proton therapy treatment for anal canal cancer performed for first time in US

Ingen files patent to produce new drug insulin thermos product

NCOA adds ILS as partner to sponsor Private Label version of online screening service for senior benefits

Christiana Care ranked among top 50 of America's best hospitals in 2 specialties

Florida Institute of Technology assists licensing CDNI-Glu compound to UK company

IAS announces winners of four scientific awards to be presented at AIDS 2010

Resveratrol concentration impacts cancer risk mitigation: Study

ICON opens purpose-built clinical pharmacology unit within CMFT campus

Pacific Shore releases clinical trial results for Burner Balm lip balm

HealthCare Appraisers opens new office in Wayne, Pennsylvania

Cage type affects laboratory mice brain

Aetna awards $75,000 grant to support Judge Glenda Hatchett's ParentPowerNow! anti-obesity program

Study examines HIV-positive patients' death risk at CD4 counts above 350

Gluten free diet reduces inflammation, improves digestion

MJO Staffing, U.S. Colleges of Health & Human Services announce strategic business collaboration

Pain medication abuse soars

Apicore announces successful conclusion of Somerset API manufacturing plant's FDA inspection

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News